Sequential chemotherapy and icotinib as first-line treatment for advanced epidermal growth factor receptor-mutated non-small cell lung cancer

BACKGROUND: Icotinib could have potential effect and tolerability when used sequentially with chemotherapy for advanced epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC). AIM: To evaluate the efficacy and safety of chemotherapy followed by icotinib maintenance therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Sheng-Jie, Han, Jin-Di, Liu, Wei, Wu, Zhi-Yong, Zhao, Xiao, Yan, Xiang, Jiao, Shun-Chang, Fang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Randomized Controlled Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254173/
https://www.ncbi.nlm.nih.gov/pubmed/35949840
http://dx.doi.org/10.12998/wjcc.v10.i18.6069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254173/
https://www.ncbi.nlm.nih.gov/pubmed/35949840
http://dx.doi.org/10.12998/wjcc.v10.i18.6069

Ejemplares similares